Axsome: Commit To Purchase Axsome Therapeutics At $85, Earn 12.7% Annualized Using Options
Investors considering a purchase of Axsome Therapeutics Inc (Symbol: AXSM) stock, but cautious about paying the going market price of $104.43/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in p
Read full article »
Axsome is a New York-based biopharmaceutical company that researches and develops novel therapies for the treatment of central nervous system disorders.
Read more